ANDERSON CYNTHIA LYNN (CHIEF FINANCIAL OFFICER) received a stock award from VISTAGEN THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/1/2025ACC: 0001415889-25-018751
Officer· CHIEF FINANCIAL OFFICER
Since Aug 2023
+6.62K
Net shares
Net buyer
$11.2K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
6.62K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.62K
Price / share
$1.70
Trade value
$11.25K
% of position
107.0%
6/30/2025
6.18K→12.80K
Total
Net shares
+6.62K
Net value
$11.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2025 | A · Award | +6.62K | $1.70 | $11.25K | 107.0% | 6.18K | 12.80K |
| Total | +6.62K | $11.25K | ||||||
Derivative Transactions0
No derivative transactions reported